(Q40574840)

21 September 2017

1 reference

title

Controversies in current immunization policy and practices: one physician's viewpoint (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A782794

27 July 2022

author name string

V. A. Fulginiti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A782794

27 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=782794

27 July 2022

publication date

1 April 1976

1 reference

Current problems in pediatrics

21 September 2017

1 reference

21 September 2017

6

1 reference

21 September 2017

6

1 reference

21 September 2017

3-25

1 reference

Bactericidal antibody in serum during infection with Bordetalla pertussis

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Evaluation of a trivalent measles, mumps, rubella vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Reinfection with rubella in pregnant women.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Combined Live Measles, Mumps, and Rubella Virus Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Clinical manifestations of postnatal and congenital rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

IMMUNITY IN MUMPS : V. THE CORRELATION OF THE PRESENCE OF DERMAL HYPERSENSITIVITY AND RESISTANCE TO MUMPS.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Gestational exposure to rubella vaccinees: a population surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Current status of global smallpox eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

An evaluation of the carcinogenicity of simian virus 40 in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Letter: Whooping-cough vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Letter: Whooping-cough vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Mumps in a northeast metropolitan community. I. Epidemiology of clinical mumps

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Rubella in an Immunized Island Population

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Live, attenuated mumps-virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

The pathology and immunology of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

The Whooping Cough Syndrome: A Continuing Pediatric Problem

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Seroconversions in Rubella-Vaccine Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

EFFICACY, POTENTIAL AND HAZARDS OF VACCINES

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Pertussis Agglutinins in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Failure of Rubella Herd Immunity during an Epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Complications of smallpox vaccination, 1968.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

A Controlled Family Study of Live, Attenuated Rubella-Virus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Pertussis: persistent problems

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Complications of immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

IMMUNITY IN MUMPS : IV. THE CORRELATION OF THE PRESENCE OF COMPLEMENT-FIXING ANTIBODY AND RESISTANCE TO MUMPS IN HUMAN BEINGS

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Rubella vaccination. A review of practical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Bacteriophages and endotoxin in licensed live-virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

1 reference

7 January 2021

Epidemiologic survey of rubella in a military recruit population

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Studies on pertussis immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Vaccination Against Poliomyelitis: an Ounce of Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Viral diseases; their control by immunologic means

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Case of apparent reinfection with rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959-65

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Agglutinin response to pertussis vaccine. I. Effect of dosage and interval

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Development of antibodies in children convalescent from whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Studies in pertussis immunity. III. Immunization of children with live and killed vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

Surveillance of mumps in the United States as background for use of vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2876%2980001-1

7 January 2021

10.1016/S0045-9380(76)80001-1

Identifiers

DOI

1 reference

21 September 2017

1 reference